Heeb M J, Mesters R M, Tans G, Rosing J, Griffin J H
Committee on Vascular Biology, Scripps Research Institute, La Jolla, California 92037.
J Biol Chem. 1993 Feb 5;268(4):2872-7.
Since plasma protein S serves an anticoagulant function by mechanisms which are not completely understood, its possible interaction with Factor Va was investigated. Human protein S bound to immobilized human Factor Va in a calcium-dependent, saturable, and reversible manner and Factor Va bound similarly to immobilized protein S. Binding of protein S to immobilized Factor V was greatly enhanced by pretreatment of the surface-bound Factor V with increasing doses of thrombin up to 1 unit/ml. Binding of protein S to Factor Va was also demonstrated in fluid phase with a Kd of 33 +/- 9 nM. Biotin-labeled heavy chain of Factor Va bound to immobilized protein S, and this binding was reversed by a 17-fold molar excess of intact unlabeled Factor Va. Protein S competed efficiently with prothrombin for binding to immobilized Factor Va. The prothrombinase activity in a reaction mixture of purified clotting factors was inhibited by protein S and exhibited a pattern of mixed inhibition. The concentration of protein S needed for 50% inhibition of the prothrombinase activity of a mixture containing 1 nM Factor Xa, 20 pM Factor Va, and 50 microM phospholipids was about 16 nM. Since not all protein S preparations exhibited this degree of prothrombinase inhibitory activity, extensive control experiments were performed to verify that the inhibitory activity was associated with protein S during immunoaffinity chromatography and was not caused by traces of activated protein C in the protein S preparations. These data show that protein S has an anticoagulant function which is independent of activated protein C and, at least in part, that this is because of its competition with prothrombin for direct binding to Factor Va.
由于血浆蛋白S通过尚未完全明确的机制发挥抗凝功能,因此对其与因子Va之间可能存在的相互作用进行了研究。人蛋白S以钙依赖性、可饱和且可逆的方式与固定化的人因子Va结合,因子Va也以类似方式与固定化的蛋白S结合。用高达1单位/毫升的递增剂量凝血酶预处理表面结合的因子V,可显著增强蛋白S与固定化因子V的结合。在液相中也证实了蛋白S与因子Va的结合,解离常数为33±9纳摩尔。生物素标记的因子Va重链与固定化的蛋白S结合,这种结合可被17倍摩尔过量的完整未标记因子Va逆转。蛋白S能有效地与凝血酶原竞争结合固定化的因子Va。纯化凝血因子反应混合物中的凝血酶原酶活性受到蛋白S的抑制,并呈现出混合抑制模式。对于含有1纳摩尔因子Xa、20皮摩尔因子Va和50微摩尔磷脂的混合物,50%抑制其凝血酶原酶活性所需的蛋白S浓度约为16纳摩尔。由于并非所有蛋白S制剂都表现出这种程度的凝血酶原酶抑制活性,因此进行了广泛的对照实验,以验证这种抑制活性在免疫亲和层析过程中与蛋白S相关,而非由蛋白S制剂中痕量的活化蛋白C引起。这些数据表明,蛋白S具有独立于活化蛋白C的抗凝功能,至少部分原因是它与凝血酶原竞争直接结合因子Va。